Women's Hair Loss · Dallas, TX
Women's Hair Loss in Dallas, TX
More hair in the shower drain. A part that keeps widening. A ponytail that feels thinner than it did. In women, hair loss is usually a symptom of something else, and the something else is testable. We look before we treat.
Why Women Are Different
Female Hair Loss Is Usually Downstream of Something.
Male pattern loss is largely genetic and DHT-driven, which is why one drug works for most men. Female loss rarely behaves that way. It is more often thyroid, iron, a hormonal shift, a stressor, or several at once, and each one points to a completely different treatment.
That is why treating a woman's scalp without testing her is guessing. Not unethical, just ineffective. If your ferritin is 14, no topical is going to fix that.
"If your loss is driven by low iron, the answer is iron. Not a $750 injection. We would rather tell you that than sell you the injection."
Ferritin. The single most common finding in women, and the one most often missed because a normal hemoglobin looks reassuring. Hair needs more iron than blood does.
Thyroid, properly. Not just TSH. Free T3, free T4, and antibodies, because subclinical thyroid disease sheds hair long before TSH looks abnormal.
Hormones. Perimenopause, postpartum shifts, coming off hormonal birth control, and androgen excess all present as thinning.
Vitamin D and DHEA-S, plus testosterone by mass spectrometry rather than immunoassay, which matters at female concentrations.
Telogen effluvium is diffuse shedding, usually two to four months after a trigger: illness, surgery, childbirth, a crash diet, major stress. It comes out everywhere at once and it is frightening. It is also usually reversible once the cause is addressed.
Female pattern loss is gradual widening at the part with the hairline preserved. Slower, less dramatic, and more likely to need ongoing treatment.
Plenty of women have both. Telling them apart changes what we do and what we tell you to expect.
Treatment
What We Actually Do About It
Chosen from what your labs show, not from a standard protocol. Many women need more than one thing, and some need nothing from this list because the answer was in the bloodwork.
Iron repletion, thyroid treatment, or hormone therapy where indicated. This is frequently the whole answer, and it is where we start. Hair responds to a corrected deficiency better than to anything applied to the scalp.
Minoxidil combined with other actives at concentrations chosen for your pattern of loss. Prescribed after your evaluation, not selected from a menu.
Growth factors from your own blood, injected into the scalp to stimulate follicle activity. PRP is $750 a session and PRF is $850. Most women do this inside a program rather than one session at a time. Used off-label.
Stimulates follicle activity and improves absorption of anything applied afterward. $400 alone, or $175 added to another scalp treatment in the same visit.
The professional Celluma NOVA Hair Growth protocol, which is not the same as general red light therapy. Included in both programs, or $49 a session on its own. Cleared for Ludwig-Savin I-1 to I-4, II-1, II-2 or frontal patterns and Fitzpatrick I to IV.
Perimenopausal and postpartum hair change is often better addressed through the underlying hormone picture than through the scalp. That work happens alongside the hair plan, not instead of it.
About finasteride and dutasteride
Navara does not prescribe finasteride or dutasteride, including topical formulations, to any woman of childbearing potential without permanent birth control. These medications can cause serious birth defects. Oral contraceptives, IUDs and implants do not meet that requirement. This is a firm rule and it is not negotiable at the visit.
Neither medication is FDA-approved for hair loss in women. What we will not do is add either one quietly to a compounded formula without discussing it properly, which is something that does happen elsewhere. Ask any provider what is in your formula and at what concentration.
Transparent Pricing
Start With Knowing Why.
Programs are the usual route, because hair responds to a course of treatment rather than to one visit. Single procedures are listed for anyone starting smaller or continuing maintenance.
What you should know before starting
Several treatments here are used off-label. Platelet-rich plasma and platelet-rich fibrin are not FDA-approved for hair restoration. Topical finasteride and dutasteride are not FDA-approved for hair loss in any formulation, and finasteride is not FDA-approved for hair loss in women at all. Off-label prescribing is legal and common when supported by clinical judgment and informed consent.
Compounded preparations are prepared by licensed 503A compounding pharmacies against an individual prescription and are not FDA-approved in the same manner as commercially manufactured drugs. Minoxidil is FDA-approved over the counter, though our compounded combinations are not.
Celluma is an FDA-cleared LED device. Clearance is a different and lower standard than approval, and the hair program is cleared for Ludwig-Savin I-1 to I-4, II-1, II-2 or frontal patterns and Fitzpatrick skin types I to IV. Outside those groups it has not been tested and may not work.
Individual response varies and no specific result can be promised. Meaningful change takes six to twelve months of consistent treatment. Early on, the realistic goal is stopping further loss rather than regrowth. Treatment eligibility is determined at your consultation.
Common Questions
What Women Ask Most
Ready to Start?
Find Out Why First.
The Hair Restoration Evaluation is $349 and covers thyroid, iron and hormones, plus your consultation, scalp assessment, baseline photography and a visit to go through what it all means. If the answer is a deficiency, you will know before you spend anything on treating the scalp.
Financing available through Cherry · Apply in minutes
Written and clinically reviewed by Jessica Boggs, MSN, APRN, FNP-C, ENP-C, founder of Navara Health. Medical oversight by Simal Patel, MD.
Last reviewed September 6, 2026. This page is general information, not medical advice, and does not create a provider relationship.
Sources